Ménard S - Search Results

1

Absence of microsatellite instability in breast carcinomas with both p53 and c-erbB-2 alterations.

Formantici C, Orlandi R, Ronchini C, Pilotti S, Ranzani GN, Colnaghi MI, Ménard S. Formantici C, et al. Among authors: menard s. J Pathol. 1999 Mar;187(4):424-7. doi: 10.1002/(SICI)1096-9896(199903)187:4<424::AID-PATH259>3.0.CO;2-0. J Pathol. 1999. PMID: 10398101

2

Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patients.

Pupa SM, Ménard S, Andreola S, Colnaghi MI. Pupa SM, et al. Among authors: menard s. Cancer Res. 1993 Dec 15;53(24):5864-6. Cancer Res. 1993. PMID: 7903196

3

Fluctuation of HER2 expression in breast carcinomas during the menstrual cycle.

Balsari A, Casalini P, Tagliabue E, Greco M, Pilotti S, Agresti R, Giovanazzi R, Alasio L, Rumio C, Cascinelli N, Colnaghi MI, Ménard S. Balsari A, et al. Among authors: menard s. Am J Pathol. 1999 Nov;155(5):1543-7. doi: 10.1016/S0002-9440(10)65470-3. Am J Pathol. 1999. PMID: 10550311 Free PMC article.

4

SEL1L expression decreases breast tumor cell aggressiveness in vivo and in vitro.

Orlandi R, Cattaneo M, Troglio F, Casalini P, Ronchini C, Ménard S, Biunno I. Orlandi R, et al. Among authors: menard s. Cancer Res. 2002 Jan 15;62(2):567-74. Cancer Res. 2002. PMID: 11809711

5

p185 HER2/neu epitope mapping with murine monoclonal antibodies.

Centis F, Tagliabue E, Uppugunduri S, Pellegrini R, Martignone S, Mastroianni A, Ménard S, Colnaghi MI. Centis F, et al. Among authors: menard s. Hybridoma. 1992 Jun;11(3):267-76. doi: 10.1089/hyb.1992.11.267. Hybridoma. 1992. PMID: 1379973

6

Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors.

Rilke F, Colnaghi MI, Cascinelli N, Andreola S, Baldini MT, Bufalino R, Della Porta G, Ménard S, Pierotti MA, Testori A. Rilke F, et al. Among authors: menard s. Int J Cancer. 1991 Aug 19;49(1):44-9. doi: 10.1002/ijc.2910490109. Int J Cancer. 1991. PMID: 1678734

7

Antigenic and immunogenic mimicry of the HER2/neu oncoprotein by phage-displayed peptides.

Orlandi R, Ménard S, Colnaghi MI, Boyer CM, Felici F. Orlandi R, et al. Among authors: menard s. Eur J Immunol. 1994 Nov;24(11):2868-73. doi: 10.1002/eji.1830241143. Eur J Immunol. 1994. PMID: 7525309

8

Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic features.

Ménard S, Squicciarini P, Luini A, Sacchini V, Rovini D, Tagliabue E, Veronesi P, Salvadori B, Veronesi U, Colnaghi MI. Ménard S, et al. Br J Cancer. 1994 Jun;69(6):1126-9. doi: 10.1038/bjc.1994.221. Br J Cancer. 1994. PMID: 7911032 Free PMC article.

9

Prognosis based on primary breast carcinoma instead of pathological nodal status.

Ménard S, Bufalino R, Rilke F, Cascinelli N, Veronesi U, Colnaghi MI. Ménard S, et al. Br J Cancer. 1994 Oct;70(4):709-12. doi: 10.1038/bjc.1994.379. Br J Cancer. 1994. PMID: 7917924 Free PMC article.

10

The extracellular domain of the c-erbB-2 oncoprotein is released from tumor cells by proteolytic cleavage.

Pupa SM, Ménard S, Morelli D, Pozzi B, De Palo G, Colnaghi MI. Pupa SM, et al. Among authors: menard s. Oncogene. 1993 Nov;8(11):2917-23. Oncogene. 1993. PMID: 8105438

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

500 results

Search Page